Neurons that produce dopamine are degraded in Parkinson’s disease. Although replacing dopamine can improve the resulting loss of motor function, such treatments can also produce involuntary movements, or dyskinesia.
Scientists in the journal PNAS investigated the molecular pathways that lead to this dyskinesia in an effort to ameliorate the condition. Because upregulating serotonin can reduce dyskinesia, the authors focused on p11, a cellular scaffold protein that increases the presence of certain serotonin receptors in the brain.
Using mice with brain lesions similar to those found in Parkinson’s disease, the authors injected small viral vectors encoding an RNA molecule that blocks p11 production in the dorsal striatum, a brain region that responds to dopamine.
Despite predictions that blocking p11 would worsen dyskinesia, the treatment improved motor function. When the mice were treated with dopamine, they showed reduced indicators of dyskinesia.
Because p11 is found throughout the brain, the authors note that systemic p11 blockade could produce side effects such as depression, but suggest that blocking p11 in the dorsal striatum alone may offer a potentially viable therapeutic strategy for Parkinson’s disease.
http://www.pnas.org/content/early/2016/01/13/1524387113
Edited
Latest News
Bone fracture healing requires nerve signaling pathway
Viruses protect themselves from CSISPR attack by building safe rooms inside bacteria
Detecting autism before symptoms appear by genome testing the siblings
3D mapping of extracellular pH of single living cells
Probiotic engineered to treat gut mucosal inflammation
Other Top Stories
Wireless, 128-channel 'WAND' for closed-loop brain stimulation and recording
Accumulation of senescent cells and aging in immune surveillance defective mice
Pro-metastatic extracellular vesicles from chemotherapy in breast cancer
The body's largest cell receptor crystallized!
Two Ways Cancer Resists Treatment Are Actually Connected, with One Activating the Other
Protocols
Dual-Angle Protocol for Doppler Optical Coherence Tomography to Improve Retinal Blood Flow Measur…
Detection of protein SUMOylation in vivo
In vivo analysis of protein sumoylation induced by a viral protein: Detection of HCMV pp71-induce…
Determination of SUMOylation sites
miR-Selection 3'UTR Target Selection Kit
Publications
Fracture repair requires TrkA signaling by skeletal sensory nerves
Predictive impact of rare genomic copy number variations in siblings of individuals with autism s…
High-resolution label-free 3D mapping of extracellular pH of single living cells
Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut
Cerebral oxygenation during locomotion is modulated by respiration
Presentations
Hypoxia Inducible Factor - 1 (HIF-1)
Intracellular Protein Degradation
Pathophysiology of Type 1 Diabetes
Plant Viruses
Regulation by changes in chromatin structure
Posters
AACC-2018-Infectious Disease
AACC-2018-Mass Spectrometry Applications
AACC-2018-Lipids/Lipoproteins
AACC-2018-Management
AACC-2018-Immunology-abstracts